Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

About Integra Lifesciences Holdings Corp (NASDAQ:IART)

Integra Lifesciences Holdings Corp logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:IART
  • CUSIP: 45798520
  • Web: www.integralife.com/
Capitalization:
  • Market Cap: $4.02 billion
  • Outstanding Shares: 78,078,000
Average Prices:
  • 50 Day Moving Avg: $50.62
  • 200 Day Moving Avg: $49.69
  • 52 Week Range: $37.71 - $56.42
P/E:
  • Trailing P/E Ratio: 62.80
  • Foreward P/E Ratio: 23.30
  • P/E Growth: 2.39
Sales & Book Value:
  • Annual Revenue: $1.05 billion
  • Price / Sales: 3.83
  • Book Value: $11.55 per share
  • Price / Book: 4.46
Profitability:
  • EBITDA: $240.98 million
  • Net Margins: 3.84%
  • Return on Equity: 4.98%
  • Return on Assets: 2.09%
Debt:
  • Debt-to-Equity Ratio: 0.97%
  • Current Ratio: 3.46%
  • Quick Ratio: 2.14%
Misc:
  • Average Volume: 576,815 shs.
  • Beta: 0.71
  • Short Ratio: 6.29
 

Frequently Asked Questions for Integra Lifesciences Holdings Corp (NASDAQ:IART)

What is Integra Lifesciences Holdings Corp's stock symbol?

Integra Lifesciences Holdings Corp trades on the NASDAQ under the ticker symbol "IART."

When did Integra Lifesciences Holdings Corp's stock split? How did Integra Lifesciences Holdings Corp's stock split work?

Integra Lifesciences Holdings Corp shares split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were payable to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of Integra Lifesciences Holdings Corp stock prior to the split would have 200 shares after the split.

How were Integra Lifesciences Holdings Corp's earnings last quarter?

Integra Lifesciences Holdings Corp (NASDAQ:IART) issued its quarterly earnings data on Wednesday, July, 26th. The company reported $0.45 EPS for the quarter, hitting the Zacks' consensus estimate of $0.45. The business had revenue of $282.16 million for the quarter, compared to analyst estimates of $283.58 million. Integra Lifesciences Holdings Corp had a return on equity of 4.98% and a net margin of 3.84%. The company's quarterly revenue was up 13.2% compared to the same quarter last year. During the same period last year, the firm posted $0.40 earnings per share. View Integra Lifesciences Holdings Corp's Earnings History.

When will Integra Lifesciences Holdings Corp make its next earnings announcement?

Integra Lifesciences Holdings Corp is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Integra Lifesciences Holdings Corp.

What guidance has Integra Lifesciences Holdings Corp issued on next quarter's earnings?

Integra Lifesciences Holdings Corp issued an update on its FY17 earnings guidance on Wednesday, July, 26th. The company provided EPS guidance of $1.88-1.94 for the period, compared to the Thomson Reuters consensus estimate of $1.92. The company issued revenue guidance of $1.125-1.14 billion, compared to the consensus revenue estimate of $1.13 billion.

Where is Integra Lifesciences Holdings Corp's stock going? Where will Integra Lifesciences Holdings Corp's stock price be in 2017?

9 analysts have issued twelve-month target prices for Integra Lifesciences Holdings Corp's stock. Their forecasts range from $46.00 to $65.00. On average, they expect Integra Lifesciences Holdings Corp's stock price to reach $53.56 in the next twelve months. View Analyst Ratings for Integra Lifesciences Holdings Corp.

Who are some of Integra Lifesciences Holdings Corp's key competitors?

Who are Integra Lifesciences Holdings Corp's key executives?

Integra Lifesciences Holdings Corp's management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board
  • Peter J. Arduini, President, Chief Executive Officer, Director
  • Glenn G. Coleman, Chief Financial Officer, Principal Accounting Officer, Corporate Vice President
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs
  • Daniel L. Reuvers, Corporate Vice President, President - Specialty Surgical Solutions

Who owns Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (1.29%), Tributary Capital Management LLC (0.48%), Nationwide Fund Advisors (0.15%), Quantitative Systematic Strategies LLC (0.01%) and Whittier Trust Co. (0.00%). Company insiders that own Integra Lifesciences Holdings Corp stock include Barbara B Hill, Christian S Schade, Daniel L Reuvers, Donald E Morel Jr, Glenn Coleman, James M Sullivan, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra Lifesciences Holdings Corp.

Who sold Integra Lifesciences Holdings Corp stock? Who is selling Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock was sold by a variety of institutional investors in the last quarter, including Nationwide Fund Advisors, Fisher Asset Management LLC and Tributary Capital Management LLC. Company insiders that have sold Integra Lifesciences Holdings Corp stock in the last year include Glenn Coleman, James M Sullivan, Peter J Arduini and Stuart Essig. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.

Who bought Integra Lifesciences Holdings Corp stock? Who is buying Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock was acquired by a variety of institutional investors in the last quarter, including Quantitative Systematic Strategies LLC and Whittier Trust Co.. Company insiders that have bought Integra Lifesciences Holdings Corp stock in the last two years include Barbara B Hill and Donald E Morel Jr. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.

How do I buy Integra Lifesciences Holdings Corp stock?

Shares of Integra Lifesciences Holdings Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra Lifesciences Holdings Corp's stock price today?

One share of Integra Lifesciences Holdings Corp stock can currently be purchased for approximately $51.50.


MarketBeat Community Rating for Integra Lifesciences Holdings Corp (NASDAQ IART)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  257 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  514
MarketBeat's community ratings are surveys of what our community members think about Integra Lifesciences Holdings Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $53.56 (3.99% upside)
Consensus Price Target History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Price Target History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Analysts' Ratings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017Jefferies Group LLCReiterated RatingBuy$58.00N/AView Rating Details
9/18/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$60.00LowView Rating Details
9/12/2017Barclays PLCReiterated RatingEqual Weight$47.00 -> $53.00HighView Rating Details
7/27/2017Raymond James Financial, Inc.Boost Price TargetOutperform$51.00 -> $55.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$65.00LowView Rating Details
5/2/2017Royal Bank Of CanadaReiterated RatingSector Perform -> Sector Perform$46.00 -> $48.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
7/13/2016J P Morgan Chase & CoInitiated CoverageOverweightN/AView Rating Details
11/12/2015Citigroup Inc.Initiated CoverageBuy$37.50N/AView Rating Details
(Data available from 10/23/2015 forward)

Earnings

Earnings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Earnings by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Earnings History by Quarter for Integra Lifesciences Holdings Corp (NASDAQ IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$0.47N/AView Earnings Details
7/26/2017Q2 2017$0.45$0.45$283.58 million$282.16 millionViewN/AView Earnings Details
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra Lifesciences Holdings Corp (NASDAQ:IART)
2017 EPS Consensus Estimate: $1.91
2018 EPS Consensus Estimate: $2.27
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.50$0.46
Q4 20174$0.55$0.65$0.59
Q1 20183$0.45$0.51$0.47
Q2 20183$0.54$0.58$0.56
Q3 20183$0.53$0.58$0.56
Q4 20183$0.61$0.74$0.68
Q1 20191$0.54$0.54$0.54
Q2 20191$0.62$0.62$0.62
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Insider Ownership Percentage: 21.50%
Institutional Ownership Percentage: 84.90%
Insider Trades by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Institutional Ownership by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Insider Trades by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/4/2017Donald E Morel JrDirectorBuy10,000$49.25$492,500.00View SEC Filing  
8/3/2017Donald E Morel JrDirectorBuy2,500$49.29$123,225.00View SEC Filing  
8/1/2017Barbara B HillDirectorBuy5,050$49.33$249,116.50View SEC Filing  
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Latest Headlines for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Source:
Loading headlines, please wait.

Social

Chart

Integra Lifesciences Holdings Corp (IART) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.